acetazolamide has been researched along with Central Serous Chorioretinopathy in 5 studies
Acetazolamide: One of the CARBONIC ANHYDRASE INHIBITORS that is sometimes effective against absence seizures. It is sometimes useful also as an adjunct in the treatment of tonic-clonic, myoclonic, and atonic seizures, particularly in women whose seizures occur or are exacerbated at specific times in the menstrual cycle. However, its usefulness is transient often because of rapid development of tolerance. Its antiepileptic effect may be due to its inhibitory effect on brain carbonic anhydrase, which leads to an increased transneuronal chloride gradient, increased chloride current, and increased inhibition. (From Smith and Reynard, Textbook of Pharmacology, 1991, p337)
Central Serous Chorioretinopathy: A visual impairment characterized by the accumulation of fluid under the retina through a defect in the retinal pigment epithelium.
| Excerpt | Relevance | Reference |
|---|---|---|
| "We sought to elucidate the influence of acetazolamide on choroidal structure changes during the treatment of central serous chorioretinopathy (CSC)." | 7.91 | Effect of Acetazolamide on Choroidal Morphology in Central Serous Chorioretinopathy. ( Baek, J; Hong, SW; Kang, NY; Kim, EC; Kwak, JH; Ra, H, 2019) |
| "To evaluate the efficacy of mineralocorticoid-receptor antagonists in comparison to acetazolamide and observation in the treatment of central serous chorioretinopathy." | 7.85 | Therapy Rationale for Mineralocorticoid-Receptor Antagonists, Acetazolamide and a Switch of Therapy in Nonresponders in Central Serous Chorioretinopathy. ( Joussen, AM; Müller, B; Rübsam, A; Schlomberg, J; Stübiger, N; Thieme, CE; Winterhalter, S, 2017) |
| "We sought to elucidate the influence of acetazolamide on choroidal structure changes during the treatment of central serous chorioretinopathy (CSC)." | 3.91 | Effect of Acetazolamide on Choroidal Morphology in Central Serous Chorioretinopathy. ( Baek, J; Hong, SW; Kang, NY; Kim, EC; Kwak, JH; Ra, H, 2019) |
| "To evaluate the efficacy of mineralocorticoid-receptor antagonists in comparison to acetazolamide and observation in the treatment of central serous chorioretinopathy." | 3.85 | Therapy Rationale for Mineralocorticoid-Receptor Antagonists, Acetazolamide and a Switch of Therapy in Nonresponders in Central Serous Chorioretinopathy. ( Joussen, AM; Müller, B; Rübsam, A; Schlomberg, J; Stübiger, N; Thieme, CE; Winterhalter, S, 2017) |
| "To describe a rare case of recurring central serous chorioretinopathy associated with retinitis pigmentosa successfully treated with oral acetazolamide." | 3.83 | RECURRENT CENTRAL SEROUS CHORIORETINOPATHY ASSOCIATED WITH RETINITIS PIGMENTOSA TREATED WITH CARBONIC ANHYDRASE INHIBITORS. ( Pomykala, M; Rubin, JS; Rubin, P, 2016) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 5 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kwak, JH | 1 |
| Hong, SW | 1 |
| Ra, H | 1 |
| Kim, EC | 1 |
| Kang, NY | 1 |
| Baek, J | 1 |
| Wuarin, R | 1 |
| Kakkassery, V | 1 |
| Consigli, A | 1 |
| Roquelaure, D | 1 |
| Papanastasiou, A | 1 |
| Schutz, JS | 1 |
| Thumann, G | 1 |
| Chronopoulos, A | 1 |
| Pomykala, M | 1 |
| Rubin, P | 1 |
| Rubin, JS | 1 |
| Rübsam, A | 1 |
| Thieme, CE | 1 |
| Schlomberg, J | 1 |
| Winterhalter, S | 1 |
| Müller, B | 1 |
| Joussen, AM | 1 |
| Stübiger, N | 1 |
| Ascaso, FJ | 1 |
| Rojo, M | 1 |
| Minguez, E | 1 |
| Cohen, SM | 1 |
| Yang, SS | 1 |
5 other studies available for acetazolamide and Central Serous Chorioretinopathy
| Article | Year |
|---|---|
Effect of Acetazolamide on Choroidal Morphology in Central Serous Chorioretinopathy.
Topics: Acetazolamide; Adult; Carbonic Anhydrase Inhibitors; Case-Control Studies; Central Serous Chorioreti | 2019 |
Combined Topical Anti-inflammatory and Oral Acetazolamide in the Treatment of Central Serous Chorioretinopathy.
Topics: Acetazolamide; Administration, Ophthalmic; Administration, Oral; Adult; Anti-Inflammatory Agents, No | 2019 |
RECURRENT CENTRAL SEROUS CHORIORETINOPATHY ASSOCIATED WITH RETINITIS PIGMENTOSA TREATED WITH CARBONIC ANHYDRASE INHIBITORS.
Topics: Acetazolamide; Administration, Oral; Adolescent; Carbonic Anhydrase Inhibitors; Central Serous Chori | 2016 |
Therapy Rationale for Mineralocorticoid-Receptor Antagonists, Acetazolamide and a Switch of Therapy in Nonresponders in Central Serous Chorioretinopathy.
Topics: Acetazolamide; Adult; Central Serous Chorioretinopathy; Cohort Studies; Female; Humans; Male; Minera | 2017 |
Diagnostic and therapeutic challenges.
Topics: Acetazolamide; Central Serous Chorioretinopathy; Female; Fluorescein Angiography; Glucocorticoids; H | 2011 |